Merus Logo Merus Logo
  • Norgine
  • Partnering
  • Products
    • ONCOLOGY SUPPORT
      • SALAGEN®
    • WOMEN'S HEALTH
      • ESTRADERM®
      • SURGESTONE®
      • PROVAMES®
      • SPECIAFOLDINE®
    • CARDIOVASCULAR
      • SINTROM®
      • ELANTAN®
      • ISOKET®
      • DEPONIT®
    • UROLOGY
      • EMSELEX® / ENABLEX®
    • INFECTIOUS DISEASE
      • VANCOCIN®
      • TREDEMINE®
  • News
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
  • Contact us

 

 

Home > News

2011 Press Releases

Announces non-brokered private placement and listing on Berlin Stock ExchangeNovember 16, 2010
Announces non-brokered private placementSeptember 22, 2010
Announces exclusive licensing agreement between Merus Labs Inc. and Innocoll Pharmaceuticals LimitedSeptember 21, 2010
Announces listing with the CNSXSeptember 15, 2010
Announces execution of binding letter of intent for the licensing, registration and distribution of specific pharmaceutical products and medical devices in CanadaJuly 6, 2010
Announces appointment of CFOMarch 31, 2010
Arrangement completedMarch 26, 2010